BIOSYNTIA ApS: Financial statements 2013
CVR: 34892970
Source: annual report 2013, Danish Business Authority
19/12/2012 – 31/12/2013
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 389,094 and a net result of DKK -27,777. Equity in the 2013 report amounted to DKK 52,223. The solvency ratio was 10.9%.
- Gross Profit
- DKK 389,094
- Profit/Loss
- DKK -27,777
- Equity
- DKK 52,223
- Total Assets
- DKK 478,545
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of December 5, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has been appointed auditor of BIOSYNTIA ApS.
As of December 5, 2013, RVT REVISIONSTJENESTEN A/S has stepped down as auditor of BIOSYNTIA ApS.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The board consists of Henrik Dalbøge (chair), Joško Bobanović and Thomas Grotkjær. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees (2018). In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity in the 2025 report amounted to DKK 32,860,576.